Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals

We examined hospital staff's perspectives on the processes, challenges, and facilitators to buprenorphine initiation and warm handoff protocols in the ED
Original research | 2021
Overdose, Wrap-around services, About prescribers, Substitution/OAT, Transitions in care/treatment, Stigma, Hospitals

Matériel d’injection : réduire les risques chez les injecteurs de médicaments opioïdes

Recommend best injection practices to reduce infections, while keeping risk in mind
Report | 2015
Harm reduction, Policy/Regulatory, Safer supply, Injecting drugs, SCS/OPS

Men’s and women’s response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder

To test whether there are gender differences in treatment outcomes among patients receiving injectable opioids for the treatment of long-term opioid-dependence.
Original research | 2017
Evidence base, Safer supply, Outcomes, Crime, Illegal drugs, Sex/Gender

Non-medical prescription opioid use and in-hospital illicit drug use among people who use drugs

Illicit drug use while admitted to hospital is common amongst people who use drugs. Furthermore, non-medical prescription opioid use (NMPOU) is increasingly being used by this population.
Original research | 2021
Evidence base, Harm reduction, Safer supply, About prescribers, Illegal drugs, Hospitals

One size does not fit all-evolution of opioid agonist treatments in a naturalistic setting over 23 years

This study aims to model the distribution of different OAT medications within a naturalistic and relatively unrestricted treatment setting (Zurich, Switzerland) over time, and to identify patient char
Original research | 2018
Evidence base, Safer supply, Advocacy, About prescribers, Substitution/OAT, Social benefits

Possible benefits of providing safe supply of substances to people who use drugs during public health emergencies such as the COVID-19 pandemic

To describe the possible benefits of offering safe supply to people who use drugs during public health emergencies like COVID-19
Commentary | 2020
Safer supply, Stimulants

Recovery capital among people receiving treatment for opioid use disorder with buprenorphine

Recovery capital is a strengths-based concept representing the sum of an individual’s resources that support recovery.
Original research | 2021
Equity, Substitution/OAT, Sex/Gender

Safe supply: What is it and what is happening in Canada?

Webpage | 2021
Overdose, Policy/Regulatory, Safer supply, Advocacy, Outcomes, Illegal drugs, Injecting drugs

Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study

In this case it is presented and discussed that if a carry was possible during the pandemic, then the carry could continue post COVID-19 to address a gap in our approach to individualize care for p

Case study | 2021
Harm reduction, Policy/Regulatory, Safer supply, Outcomes, Injecting drugs, Diversion, Carries/take-home doses

The Andalusian trial on heroin-assisted treatment: a 2 year follow-up

In 2003, a randomised controlled trial comparing injected diacetylmorphine and oral methadone was carried out in Andalusia, Spain.
Original research | 2010
Evidence base, Harm reduction, Policy/Regulatory, Safer supply, About prescribers, Outcomes, Substitution/OAT

The cost and impact of distributing naloxone to people who are prescribed opioids to prevent opioid-related deaths: findings from a modelling study

Although most opioid-related mortality in Australia involves prescription opioids, most research to understand the impact of naloxone supply on opioid-related mortality has focused upon people who inj
Original research | 2021
Mortality, Harm reduction, Policy/Regulatory, About prescribers

Voices of Experience: Attitudes and Opinions of Recipients of Unsupervised Injectable Opiate Treatment in the Northwest of England

To describe the views and experiences of drug users receiving unsupervised injectable opiate treatment (IOT) for opiate addiction
Original research | 2009
Safer supply, About PWUD, Outcomes, Crime, Social benefits

Community based low threshold substance use services: Practitioner approaches and challenges

To explore the efficacy and challenges of delivering low threshold substance use services within a community setting, with particular consideration of practitioner approaches
Report | 2016
Evidence base, Wrap-around services, About prescribers, Social services, Barriers and enablers, Outcomes

Could a drug-checking service increase intention to use ecstasy at a festival?

Calls to provide sanctioned drug-checking (pill testing) at Australian music festivals have been met with resistance from most governments due to concerns that such services would increase use of ecst
Original research | 2021
Evidence base, Harm reduction, Hesitancy of prescribers , Advocacy, Illegal drugs, Drug checking

Effect of filtration on morphine and particle content of injections prepared from slow-release oral morphine tablets

Examine contaminants and filtration methods for injecting crushed tablets of slow-release morphone
Original research | 2009
Harm reduction, Safer supply, About PWUD, Injecting drugs

Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic – is an update of legal restrictions warranted?

In light of the COVID-19 pandemic, the Swiss Federal Council provisionally adapted its policy, allowing for longer prescriptions of take-home diacetylmorphine.

Original research | 2021
Evidence base, Policy/Regulatory, Safer supply, About prescribers, About PWUD, Barriers and enablers, Carries/take-home doses

Harm Reduction Satellite Sites: A Guide for Operating Harm Reduction Hubs from the Homes of People Who Use Drugs

This program guide was developed based on our experiences at two Toronto-based community health centres developing Satellite site programming out of the homes of people who use drugs.
Guidelines | 2020
Overdose, Harm reduction, Safer supply, Decriminalization/legalization, Equity, Advocacy, About PWUD, Barriers and enablers, Peer/PWLLE program involvement

Hospitals as a 'risk environment': an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs

This ethno-epidemiological study was undertaken in Vancouver, Canada to explore how the social-structural dynamics within hospitals function to produce discharges against medical advice among PWID.
Original research | 2014
Withdrawal, Harm reduction, Policy/Regulatory, About PWUD, Illegal drugs, SCS/OPS, Hospitals

Injection of Pharmaceuticals Designed for Oral Use: Harms Experienced and Effective Harm Reduction Through Filtration. Non-medical and illicit use of psychoactive drugs

Since these products are designed for oral administration, they can contain excipients (ingredients other than the drug) which are poorly soluble, resulting in suspension of particles in the injection
Book | 2017
Harm reduction, Safer supply, About PWUD, Injecting drugs

Lacking evidence for the association between frequent urine drug screening and health outcomes of persons on opioid agonist therapy

Assess the effect of and recommendations for urine drug screening on health outcomes for persons with OUD who receive OAT
Lit review | 2018
Evidence base, Policy/Regulatory, Safer supply

Affiner votre recherche

Mots clés
Format
Région